SEC Form 4 · accession 0001093557-18-000181
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven R Altman
Director
Period of report
Aug 24, 2018
Accepted (ET)
Aug 28, 2018 · 8:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 24, 2018 | S | 5,000 | $136.4718 | D | 0 | I | By Foundation |
| Common Stock | holding | — | — | — | 3,449 | D | ||
| Common StockF3 | holding | — | — | — | 57,855 | I | by Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $136.47 to $136.56. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- F2Shares held by The Lisa and Steve Altman Family Foundation with respect to which the reporting person is an authorized agent.
- F3Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee.